You just read:

New Study Led By John Theurer Cancer Center Researcher Demonstrates Potential Therapeutic Benefit Of TPI 287 With Bevacizumab In Treatment Of Aggressive Brain Cancer

News provided by

John Theurer Cancer Center

04 Jun, 2016, 14:00 ET